Video

Dr. Susan Slovin summarizes state of PARP inhibitor use in prostate cancer

Video Player is loading.
Current Time 0:00
Duration 1:57
Loaded: 8.41%
Stream Type LIVE
Remaining Time 1:57
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Susan F. Slovin, MD, PhD, medical oncologist, associate vice chair, Academic Administration, Department of Medicine, Memorial Sloan Kettering Cancer Center, provides a concise summary of the latest information on the state of PARP inhibitors for the treatment of patients with prostate cancer.

    Newsletter

    Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

    © 2025 MJH Life Sciences

    All rights reserved.